PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study

BACKGROUND: Whether intensity-modulated radiotherapy (IMRT) can enhance the efficacy of the programmed death (PD)-1 inhibitors combined with anti-angiogenic therapy for hepatocellular carcinoma (HCC) is unclear. Therefore, we conducted this multicenter retrospective study to investigate the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Ke, Guo, Lu, Ma, Wenqiong, Wang, Jing, Xie, Yunchuan, Rao, Mingyue, Zhang, Jianwen, Li, Xueting, Wen, Lianbin, Li, Bo, Yang, Xiaoli, Song, Yanqiong, Huang, Weihong, Chi, Hao, Gu, Tao, Xu, Ke, Liu, Yanlin, Chen, Jiali, Wu, Zhenying, Jiang, Yi, Li, Han, Zeng, Hao, Wang, Pan, Feng, Xunjie, Chen, Siyu, Yang, Binbin, Jin, Hongping, He, Kun, Han, Yunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539675/
https://www.ncbi.nlm.nih.gov/pubmed/36211350
http://dx.doi.org/10.3389/fimmu.2022.972503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539675/
https://www.ncbi.nlm.nih.gov/pubmed/36211350
http://dx.doi.org/10.3389/fimmu.2022.972503

Ejemplares similares